ATE174917T1 - Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel - Google Patents
Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittelInfo
- Publication number
- ATE174917T1 ATE174917T1 AT91913666T AT91913666T ATE174917T1 AT E174917 T1 ATE174917 T1 AT E174917T1 AT 91913666 T AT91913666 T AT 91913666T AT 91913666 T AT91913666 T AT 91913666T AT E174917 T1 ATE174917 T1 AT E174917T1
- Authority
- AT
- Austria
- Prior art keywords
- lower alkyl
- substituted
- hydroxy
- phenyl
- hydrogen
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- -1 hydroxy, carboxyl Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9070791 | 1991-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE174917T1 true ATE174917T1 (de) | 1999-01-15 |
Family
ID=14006001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91913666T ATE174917T1 (de) | 1991-04-22 | 1991-08-06 | Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel |
Country Status (12)
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0628559B1 (en) * | 1993-06-10 | 2002-04-03 | Beiersdorf-Lilly GmbH | Pyrimidine compounds and their use as pharmaceuticals |
| EP0714898B1 (en) * | 1994-06-21 | 2001-11-14 | Otsuka Pharmaceutical Factory, Inc. | PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE |
| RU2147584C1 (ru) * | 1995-10-27 | 2000-04-20 | Американ Цианамид Компани | Способ получения дигалоидазолопиримидинов и способ получения дигидроксиазолопиримидинов |
| US6664261B2 (en) * | 1996-02-07 | 2003-12-16 | Neurocrine Biosciences, Inc. | Pyrazolopyrimidines as CRF receptor antagonists |
| EP0915093B1 (en) * | 1996-06-06 | 2002-11-27 | Otsuka Pharmaceutical Factory, Inc. | Amide derivatives |
| US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
| US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
| ATE375344T1 (de) * | 1996-07-24 | 2007-10-15 | Bristol Myers Squibb Pharma Co | Azolotriazine und pyrimidine |
| CZ299451B6 (cs) * | 1996-07-24 | 2008-07-30 | Bristol-Myers Squibb Pharma Company | [1,5-a]-Pyrazolo-1,3,5- triaziny jejich použití afarmaceutické kompozice na jejich bázi |
| US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| HUP9603001A3 (en) * | 1996-10-30 | 1999-07-28 | Richter Gedeon Vegyeszet | Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same |
| AU4331500A (en) | 1999-04-06 | 2000-10-23 | Du Pont Pharmaceuticals Company | Pyrazolotriazines as crf antagonists |
| WO2000059908A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
| US20020061897A1 (en) * | 2000-03-30 | 2002-05-23 | Elliott Richard L. | Neuropeptide Y antagonists |
| US6630476B2 (en) | 2000-07-07 | 2003-10-07 | Bristol-Myers Squibb Pharma Company | Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists |
| JP2004525937A (ja) | 2001-03-27 | 2004-08-26 | ニューロジェン コーポレイション | （オキソ−ピラゾロ［１，５ａ］ピリミジン−２−イル）アルキル−カルボキサミド |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| WO2003101993A1 (en) * | 2002-06-04 | 2003-12-11 | Neogenesis Pharmaceuticals, Inc. | Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents |
| ATE362474T1 (de) | 2002-09-04 | 2007-06-15 | Schering Corp | Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen |
| NZ539163A (en) | 2002-09-04 | 2007-03-30 | Schering Corp | Pyrazolo[1,5-a]pyrimidine compounds useful as cyclin dependent kinase (CDK) inhibitors |
| US7161003B1 (en) | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US7205308B2 (en) * | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| JP2006501260A (ja) * | 2002-09-04 | 2006-01-12 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン |
| US7196078B2 (en) * | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| PL224879B1 (pl) | 2002-09-04 | 2017-02-28 | Pharmacopeia Drug Discovery Inc | Pirazolo [1,5-a] pirymidynowy związek, jego zastosowanie do wytwarzania leku oraz zawierająca go farmaceutyczna kompozycja |
| US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
| US8580782B2 (en) | 2002-09-04 | 2013-11-12 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
| EP1534710B1 (en) * | 2002-09-04 | 2007-10-24 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US7557110B2 (en) | 2003-02-28 | 2009-07-07 | Teijin Pharma Limited | Pyrazolo[1,5-A] pyrimidine derivatives |
| EP1608652A1 (en) * | 2003-03-31 | 2005-12-28 | Vernalis (Cambridge) Limited | Pyrazolopyrimidine compounds and their use in medicine |
| US6949895B2 (en) * | 2003-09-03 | 2005-09-27 | Axcelis Technologies, Inc. | Unipolar electrostatic quadrupole lens and switching methods for charged beam transport |
| PE20051089A1 (es) * | 2004-01-22 | 2006-01-25 | Novartis Ag | Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina |
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| JP2009507843A (ja) * | 2005-09-09 | 2009-02-26 | シェーリング コーポレイション | アザ縮合サイクリン依存性キナーゼ阻害剤 |
| WO2007041712A1 (en) | 2005-10-06 | 2007-04-12 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| WO2007044426A2 (en) * | 2005-10-06 | 2007-04-19 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| JP2010511058A (ja) | 2006-11-29 | 2010-04-08 | アボット・ラボラトリーズ | ジアシルグリセロールｏ−アシルトランスフェラーゼ１型酵素の阻害薬 |
| JP5421925B2 (ja) | 2007-12-19 | 2014-02-19 | ジェネンテック， インコーポレイテッド | ５−アニリノイミダゾピリジン及び使用の方法 |
| PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| WO2011076765A1 (en) * | 2009-12-23 | 2011-06-30 | Katholieke Universiteit Leuven | Novel antiviral compounds |
| US8927562B2 (en) * | 2010-09-28 | 2015-01-06 | Merck Sharp & Dohme Corp. | Fused tricyclic inhibitors of mammalian target of rapamycin |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| WO2012065963A2 (en) | 2010-11-15 | 2012-05-24 | Katholieke Universiteit Leuven | Novel antiviral compounds |
| US8633198B1 (en) | 2011-09-20 | 2014-01-21 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
| KR101868128B1 (ko) * | 2013-12-11 | 2018-06-18 | 난트 홀딩스 아이피, 엘엘씨 | 인플루엔자 a rna-의존성 rna 폴리머라제의 저분자 저해제 |
| AU2015208205B2 (en) | 2014-01-22 | 2019-12-05 | Curovir Ab | Pyrazolo[1,5-a]pyrimidines as antiviral compounds |
| GB201410817D0 (en) | 2014-06-17 | 2014-07-30 | Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D | Therapeutic agents |
| MX2020002869A (es) * | 2017-09-15 | 2020-07-24 | Aduro Biotech Inc | Compuestos de pirazolopirimidinona y usos de los mismos. |
| DE102018201598A1 (de) | 2018-02-02 | 2019-08-08 | Beiersdorf Ag | Stabile Wundheilsalbe |
| KR20230096026A (ko) | 2020-10-23 | 2023-06-29 | 일동제약(주) | Cftr 조절제 화합물, 그의 조성물 및 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792533A (fr) * | 1971-12-09 | 1973-06-08 | Int Chem & Nuclear Corp | Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation |
| US3925385A (en) * | 1972-04-20 | 1975-12-09 | Icn Pharmaceuticals | 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines |
| US4026893A (en) * | 1975-11-07 | 1977-05-31 | Squibb & Sons Inc | Pyrazolo{8 1,5-a{9 pyrido{8 3,2-e{9 pyrimidine-7-carboxylic acid derivatives |
| DE3338292A1 (de) * | 1983-10-21 | 1985-05-02 | Basf Ag, 6700 Ludwigshafen | 7-amino-azolo(1,5-a)-pyrimidine und diese enthaltende fungizide |
| JPS60100381A (ja) * | 1983-11-04 | 1985-06-04 | Yuasa Battery Co Ltd | 密閉形鉛蓄電池 |
| JPS60100581A (ja) * | 1983-11-07 | 1985-06-04 | S D S Baiotetsuku:Kk | ピラゾロ〔１，５−ａ〕ピリミジン誘導体，それらを含有する農園芸用殺菌剤及びそれらの製造方法 |
| JPS6157587A (ja) * | 1984-08-29 | 1986-03-24 | Shionogi & Co Ltd | 縮合複素環誘導体および抗潰瘍剤 |
| JP2585462B2 (ja) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | ピラゾロ［１，５―ａ］ピリミジン誘導体 |
| CA2100514C (en) * | 1992-07-29 | 2005-03-29 | Johannes A. M. Hamersma | 17-spiromethylene steroids |
-
1991
- 1991-08-06 AU AU82958/91A patent/AU651986B2/en not_active Ceased
- 1991-08-06 KR KR1019930703210A patent/KR100191774B1/ko not_active Expired - Fee Related
- 1991-08-06 WO PCT/JP1991/001043 patent/WO1992018504A1/ja active IP Right Grant
- 1991-08-06 ES ES91913666T patent/ES2126573T3/es not_active Expired - Lifetime
- 1991-08-06 CA CA002107479A patent/CA2107479C/en not_active Expired - Fee Related
- 1991-08-06 DE DE69130683T patent/DE69130683T2/de not_active Expired - Fee Related
- 1991-08-06 EP EP91913666A patent/EP0591528B1/en not_active Expired - Lifetime
- 1991-08-06 AT AT91913666T patent/ATE174917T1/de not_active IP Right Cessation
- 1991-08-06 US US08/133,086 patent/US5688949A/en not_active Expired - Fee Related
- 1991-08-06 DK DK91913666T patent/DK0591528T3/da active
- 1991-08-16 TW TW080106516A patent/TW221434B/zh active
-
1992
- 1992-03-13 JP JP4055370A patent/JPH0570353A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69130683D1 (de) | 1999-02-04 |
| AU8295891A (en) | 1992-11-17 |
| WO1992018504A1 (fr) | 1992-10-29 |
| ES2126573T3 (es) | 1999-04-01 |
| EP0591528A4 (en) | 1995-02-15 |
| KR100191774B1 (ko) | 1999-06-15 |
| DE69130683T2 (de) | 1999-05-06 |
| DK0591528T3 (da) | 1999-08-23 |
| EP0591528A1 (en) | 1994-04-13 |
| US5688949A (en) | 1997-11-18 |
| TW221434B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-03-01 |
| JPH0570353A (ja) | 1993-03-23 |
| AU651986B2 (en) | 1994-08-11 |
| CA2107479C (en) | 1997-12-16 |
| EP0591528B1 (en) | 1998-12-23 |
| CA2107479A1 (en) | 1992-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE174917T1 (de) | Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel | |
| ES2076827T3 (es) | Azaindoles, procedimientos de preparacion y medicamentos que los contienen. | |
| ATE206412T1 (de) | Heterocyclische verbindungen als bradykinin antagonisten | |
| ATE174596T1 (de) | Imidazo (1,2-a)pyridine als bradykinin- antagonisten | |
| CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
| GB2230527B (en) | Aminopyrimidine derivatives useful for treating cardiovascular disorders | |
| EE03139B1 (et) | Piperasiiniderivaadid, nende kasutamine ja farmatseutiline kompositsioon | |
| DK0509398T3 (da) | Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse | |
| BG100069A (bg) | Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им | |
| DK0665834T3 (da) | Quinolon- og acridinonderivater til behandling af urininkontinens | |
| NZ330078A (en) | Active oxygen carriers containing pterin derivatives and salts thereof for use as cosmetic agents and feed | |
| DK0625516T3 (da) | Benzensulfonamidderivater til behandling af blæreustabilitet | |
| NZ244892A (en) | 6-(1h-imidazol-1-ylmethyl)-2-phenylquinoline derivatives and pharmaceutical compositions | |
| DE69619259D1 (de) | Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase | |
| DK0579968T3 (da) | 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
| ATE176782T1 (de) | Heterocyclische verbindungen und pharmazeutische verwendung | |
| DE69311123D1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe | |
| DE3764667D1 (de) | Substituierte carbonsaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE66219T1 (de) | Pyrrol-derivate, ihre herstellung und pharmazeutische zusammenstellungen, die sie enthalten. | |
| DK0421668T3 (da) | 1,4-dihydro-4-oxo-3-quinolinderivater som selektivt toksiske, antibakterielle midler til pattedyr | |
| IL101032A0 (en) | 1,2,4-triazolo(1,5-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |